Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Paediatric Drugs|August 14, 2012
Relapsed or refractory pediatric acute lymphoblastic leukemia: current and emerging treatmentsAlissa Martin, Elaine Morgan, Nobuko HijiyaJournal of Clinical Microbiology|August 31, 2002
Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar IIITom Coenye, Theodore Spilker, Alissa Martin, et al.FEMS Microbiology Letters|November 13, 2003
Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosisRhiannon Biddick, Theodore Spilker, Alissa Martin, et al.Journal of Pediatric Hematology/Oncology|September 1, 2017
Treatment of Refractory Infantile Hemangiomas and Pulmonary Hypertension With Sirolimus in a Pediatric PatientKelley K Hutchins, Robert D Ross, Daisuke Kobayashi, et al.Biochemical and Biophysical Research Communications|October 15, 2013
MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastomaAlissa Martin, Aunica Jones, Paul J Bryar, et al.Journal of Pediatric Hematology/Oncology|December 3, 2019
Reversible Cerebral Vasoconstriction Syndrome and Sickle Cell Disease: A Case ReportKatherine Regling, Daniel Pomerantz, Sandra Narayanan, et al.Pediatric Hematology and Oncology|October 18, 2017
Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemiaYoav Messinger, Jessica Boklan, John Goldberg, et al.Plos One|September 18, 2015
Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma ProliferationVanessa Montoya, Hanli Fan, Paul J Bryar, et al.Pediatric Blood & Cancer|March 18, 2014
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastomaAlissa Martin, Jennifer Schneiderman, Irene B Helenowski, et al.Pageof 2